BioLineRx Ltd. (TLV:BLRX)
1.800
-0.100 (-5.26%)
Nov 6, 2025, 5:24 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $304.00K USD in the quarter ending June 30, 2025, a decrease of -94.36%. This brings the company's revenue in the last twelve months to $17.25M, up 1.19% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$17.25M
Revenue Growth
+1.19%
P/S Ratio
0.81
Revenue / Employee
$616.11K
Employees
28
Market Cap
46.99M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.94M | 24.14M | 502.92% |
| Dec 31, 2023 | 4.80M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.84B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 571.15M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 155.27M |
BioLineRx News
- 5 weeks ago - BioLineRx Ltd. (BLRX) Investor Call (Transcript) - Seeking Alpha
- 5 weeks ago - BioLineRx Ltd. - Special Call - Seeking Alpha
- 5 weeks ago - BioLineRx (BLRX) and Hemispherian Collaborate on Innovative Cancer Therapy - GuruFocus
- 5 weeks ago - BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers - PRNewsWire
- 3 months ago - BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 3 months ago - BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Earnings Scheduled For August 14, 2025 - Benzinga